Provided by Tiger Trade Technology Pte. Ltd.

Orchestra BioMed

5.36
-0.0700-1.29%
Post-market: 5.360.00000.00%19:30 EDT
Volume:276.67K
Turnover:1.50M
Market Cap:320.96M
PE:-5.36
High:5.53
Open:5.45
Low:5.27
Close:5.43
52wk High:5.78
52wk Low:2.20
Shares:59.88M
Float Shares:33.00M
Volume Ratio:0.45
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9995
EPS(LYR):-1.1091
ROE:-397.30%
ROA:-45.73%
PB:16.61
PE(LYR):-4.83

Loading ...

Orchestra BioMed shareholders approved 2026 annual meeting proposals

Reuters
·
Jun 24

Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG

TIPRANKS
·
Jun 18

Orchestra BioMed posts investor deck spotlighting pivotal-stage AVIM hypertension therapy and Virtue sirolimus balloon program

Reuters
·
Jun 04

Orchestra BioMed CEO, Chair David P. Hochman acquires 5,000 common shares worth $19,150

Reuters
·
Jun 03

Orchestra BioMed COO Darren Sherman disposes of 15,000 common shares worth $58,050

Reuters
·
Jun 03

Orchestra BioMed grants options for 85,500 shares to five new hires under inducement plan

Reuters
·
Jun 03

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 03

Top Brass Double Down on Orchestra BioMed as Insider Buying Heats Up

TIPRANKS
·
May 20

Orchestra BioMed Holdings Is Maintained at Buy by B. Riley Securities

Dow Jones
·
May 20

Orchestra BioMed CEO joins Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 19

Orchestra BioMed CEO, Chair David Hochman buys 5,000 shares for $18,850

Reuters
·
May 19

Orchestra BioMed director Aryeh Jason buys 8,971 shares valued at $34,986.9

Reuters
·
May 19

B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating

MT Newswires Live
·
May 19

Orchestra BioMed director Eric S. Fain acquires 20,000 shares worth $82,600

Reuters
·
May 18

Orchestra BioMed releases corporate presentation on pivotal-stage AVIM hypertension and Virtue SAB programs

Reuters
·
May 14

Orchestra BioMed Holdings Is Maintained at Overweight by Barclays

Dow Jones
·
May 13

Orchestra BioMed price target raised to $13 from $12 at Barclays

TIPRANKS
·
May 13

Orchestra BioMed reports Q1 EPS (33c), consensus (44c)

TIPRANKS
·
May 13

Orchestra Biomed Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Orchestra BioMed Hldgs Q1 EPS $(0.33) Beats $(0.41) Estimate, Sales $110.000K Miss $190.750K Estimate

Benzinga Earnings
·
May 13